News & Updates
Filter by Specialty:
Early-life exposures to smoking, infection, abuse up risk of COPD in adulthood
Childhood respiratory disease, maltreatment, maternal smoking, and low birth weight are all associated with an increased risk of chronic obstructive pulmonary disease (COPD) in adulthood, a study has found.
Early-life exposures to smoking, infection, abuse up risk of COPD in adulthood
19 Dec 2021
No benefit from adding interferon beta-1a to remdesivir in COVID-19
Adding interferon beta-1a to remdesivir did not hasten time to recovery among adults hospitalized with COVID-19, according to results of the phase III ACTT*-3 trial.
No benefit from adding interferon beta-1a to remdesivir in COVID-19
16 Dec 2021
Radiographic progression of interstitial lung disease portends long-term mortality risk
Among patients with systemic sclerosis-interstitial lung disease (SSc-ILD), radiographic progression of ILD over time is predictive of elevated long-term mortality, as shown in a study.
Radiographic progression of interstitial lung disease portends long-term mortality risk
14 Dec 2021
Is prior allergy a deal-breaker for COVID-19 vacc?
A large prospective, observational study has suggested that while individuals with a history of high-risk allergy may have an increased risk of allergic reactions following receipt of a messenger RNA (mRNA) COVID-19 vaccine, they are still able to receive both vaccine doses.
Is prior allergy a deal-breaker for COVID-19 vacc?
13 Dec 2021
Carbocisteine, gingko leaf extract boost milrinone’s efficacy against COPD complicated by PAH
The combination of carbocisteine, gingko leaf extract, and milrinone yields significant clinical improvement in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD), a recent study has found. In turn, this treatment regimen also leads to better patient quality of life.